These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

44 related articles for article (PubMed ID: 14560601)

  • 1. [Physiopathology and treatment of HAM].
    Osame M; Usuku K; Umehara F; Saito M; Furukawa Y; Kubota R; Nagai M; Higuchi I; Nakagawa M; Arimura K; Izumo S
    Nihon Naika Gakkai Zasshi; 2003 Sep; 92(9):1673-82. PubMed ID: 14560601
    [No Abstract]   [Full Text] [Related]  

  • 2. [Physiopathology and therapy of HTLV-I-associated myelopathy].
    Kira J
    Fukuoka Igaku Zasshi; 1996 Jan; 87(1):1-7. PubMed ID: 8820981
    [No Abstract]   [Full Text] [Related]  

  • 3. [HTLV-I-associated myelopathy (HAM)].
    Osame M
    Tanpakushitsu Kakusan Koso; 1990 May; 35(7 Suppl):1320-6. PubMed ID: 2356333
    [No Abstract]   [Full Text] [Related]  

  • 4. Recent studies on the epidemiology, clinical features and pathogenic mechanisms of HTLV-I associated myelopathy (HAM/TSP) and other diseases associated to HTLV.
    Osame M; Nakagawa M; Umehara F; Ijichi S; Moritoyo T; Higuchi I; Usuku K; Arimura K; Izumo S
    J Neurovirol; 1997 May; 3 Suppl 1():S50-1. PubMed ID: 9179793
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of spastic paraparesis with botulinum toxin with reference to beneficial effects, disease severity and long-term treatment].
    Takenaga S; Kawahigashi Y; Sonoda Y; Horikiri T; Hirata K; Arimura K; Osame M
    Rinsho Shinkeigaku; 1995 Mar; 35(3):251-5. PubMed ID: 7614746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Tropical spastic paraparesis (HAM/TSP) in different regions of the world. Subclinical and geographic differences in neurophysiologic studies].
    León-S FE; Zaninovic V; Osame M; Arimura K; Arimura Y
    Rev Med Chil; 1994 Mar; 122(3):265-73. PubMed ID: 7809516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disability and determinants of gait performance in tropical spastic paraparesis/HTLV-I associated myelopathy (HAM/TSP).
    Franzoi AC; Araújo AQ
    Spinal Cord; 2007 Jan; 45(1):64-8. PubMed ID: 16568145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [HTLV-I--associated myelopathy/tropical spastic paraparesis (HAM/TSP)].
    Makino M
    Ryoikibetsu Shokogun Shirizu; 2000; (31):9-12. PubMed ID: 11269197
    [No Abstract]   [Full Text] [Related]  

  • 9. Reduction in HTLV-I proviral load and spontaneous lymphoproliferation in HTLV-I-associated myelopathy/tropical spastic paraparesis patients treated with humanized anti-Tac.
    Lehky TJ; Levin MC; Kubota R; Bamford RN; Flerlage AN; Soldan SS; Leist TP; Xavier A; White JD; Brown M; Fleisher TA; Top LE; Light S; McFarland HF; Waldmann TA; Jacobson S
    Ann Neurol; 1998 Dec; 44(6):942-7. PubMed ID: 9851439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of IL-15 in the pathogenesis of human T lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis: implications for therapy with a monoclonal antibody directed to the IL-2/15R beta receptor.
    Azimi N; Jacobson S; Leist T; Waldmann TA
    J Immunol; 1999 Oct; 163(7):4064-72. PubMed ID: 10491011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Botulinum toxin trial for spasticity].
    Mezaki T; Kaji R; Kimura J
    Rinsho Shinkeigaku; 1992 Jun; 32(6):637-8. PubMed ID: 1424345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How helpful is thoracic paraspinal EMG in HAM/TSP?
    Arimura K; Arimura Y; Moritoyo H; Tokimura Y; Takenaga S; Sonoda Y; Yamanaka H; Nakagawa M; Izumo S; Osame M
    Muscle Nerve; 1995 Feb; 18(2):248-50. PubMed ID: 7823988
    [No Abstract]   [Full Text] [Related]  

  • 13. [Human T-cell lymphotropic virus Type I (HTLV-I) as a cause of progressive myelopathy].
    Portegies P; Goudsmit J
    Ned Tijdschr Geneeskd; 1991 Jul; 135(29):1302-6. PubMed ID: 1865933
    [No Abstract]   [Full Text] [Related]  

  • 14. [Efficacy of leukocytapheresis and low-dose prednisolone treatment in a patient with HTLV-I-associated myelopathy (HAM)].
    Ijichi S; Ijichi N; Osame M; Izumihara T; Niimura T
    Rinsho Shinkeigaku; 1990 May; 30(5):544-7. PubMed ID: 2401115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical evolution of tropical spastic paraparesis: The Tumaco experience.
    Bernal N; Bernal E; Patarca R; Concha M; Trujillo JM; Bonilla RD; Arango C
    J NeuroAIDS; 1999; 2(2):37-41. PubMed ID: 16873192
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical neurophysiological comparative study on HTLV-1 associated myelopathy/tropical spastic paraparesis.
    Leon-S FE; Arimura K; Arimura Y; Sonoda Y; Suwazono S; Osame M
    Arch Med Res; 1995; 26(4):397-403. PubMed ID: 8555734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Therapy for HAM/TSP and AIDS].
    Nakagawa M; Maruyama Y; Osame M
    Nihon Rinsho; 1994 Nov; 52(11):3019-25. PubMed ID: 7996704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [HTLV-I-associated myelopathy (HAM)].
    Izumo S
    Uirusu; 2002 Dec; 52(2):239-44. PubMed ID: 12685314
    [No Abstract]   [Full Text] [Related]  

  • 19. [Therapeutic effect of lymphocytapheresis on patients with HTLV-I-associated myelopathy (HAM)].
    Kubota R; Nakagawa M; Nakamura A; Osame M
    Rinsho Shinkeigaku; 1992 Sep; 32(9):984-8. PubMed ID: 1300272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tropical spastic paraparesis from northern India.
    Agrawal A; Malviya A; Singh NK
    J Assoc Physicians India; 2006 Sep; 54():746-7. PubMed ID: 17212030
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.